HIPINE

2583
66.8506.45% ( +4.050 )
Delay Closed: Nov 16, 16:08:11

Overview

HIPINE (2583)

Shenzhen Hipine Precision Technology Co., Ltd., together with its subsidiaries, researches, designs, develops, manufactures, and sells watches and related acces...

Open
63.000
High
69.000
Low
62.750
Prev. Close
62.800
Volume
1.26M
Turnover
83.20M
Avg Price
66.288
Bid/Ask Ratio
-27.27%
Amplitude
9.95%
52wk High
215.420
Volume Ratio
5.83
Turnover Ratio
2.13%
52wk Low
37.460
HK Mkt Cap
3.93B
Market CapHKD
3.93B
P/ETTM
23.62
P/EDynamic
17.21
P/EStatic
--
EPSTTM
2.83
EPSDynamic
3.88
EPSStatic
--
BVPS
22.11
P/B
3.02
HK Shares
58.83M
Dividend YieldTTM
0.87%
DividendTTM
0.58
Shares
58.83M
Min lot size
100
Currency
HKD

HIPINE Analyst Rating

View more

Forecast & Rating

Jun 8, 2026
Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Nov, 16

    Hipine (2583.HK) closed up about 6.8% at HK$67.05 after spiking to HK$68.75 in the morning session and fading to HK$63.95 in the afternoon before recovering, a spike-and-fade shape against a HK$62.80 prior close on 1.25 million shares and HK$82.6 million turnover; a roughly 21% weekly gain and repeated top-gainer listings point to active capital as the direct driver. Fundamentals cut against the price: Q2 2026 revenue of HK$192.5 million rose 22.2% yoy, net profit HK$57.2 million up 84.8%, net margin 29.7% and EPS HK$0.9728 up 51.5%, yet the stock sits 69.0% below its January 26 high of HK$216 and down 60.1% year to date, though 76.3% above the October 7 low of HK$38.04 and above MA20 (HK$50.49) and MA60 (HK$56.89); an October controlling-shareholder stake sale had earlier triggered a sharp pullback. Though afternoon volume did not expand, the intraday give-back leaves short-term positioning unstable.

  2. Nov, 13

    HIPINE (2583.HK) opened lower but climbed to close up 7.9% at HK$62.90, dipping to HK$58.05 at 09:34 before grinding higher to an intraday HK$63.35 at 15:06 on late-session volume, with a turnover rate of 1.59%. The move looks flow-driven rather than news-led: southbound accumulation has been building, with a near-40% three-day rally and a single-session jump of over 16% occurring without clear catalysts, and the latest report notes a 6% one-day gain. Fundamentals offer some ballast, Q2 2026 revenue of HK$192.5m rose 22.2% year on year, net profit of HK$57.2m rose 84.8%, net margin reached 29.7% and EPS of HK$0.9728 was up 51.5%. Still, at HK$62.90 the shares sit 70.9% below the January 26 52-week high of HK$216 and down 62.6% year to date, barely above the MA20 of HK$49.39 and MA60 of HK$56.76. While a controlling shareholder stake sale after the earlier rally remains an overhang.

  3. Nov, 12

    In Hong Kong trading, shares reversed an intraday rally and ended at HK$57.10, down 1.04% from the previous close of HK$57.70, after swinging between HK$55.55 and HK$62.20; the stock opened at HK$56.75, peaked at HK$62.20 in the afternoon session and then faded. The move came as the market digested a recent controlling-shareholder stake sale and the after-effects of a southbound capital-driven rally, while absent fresh company announcements capital flows amplified intraday swings. Fundamentals remain firm: Q2 2026 revenue rose 22.18% year on year to HK$192.5 million, net profit jumped 84.79% to HK$57.2 million, net margin was 29.73%, EPS increased 51.49% to HK$0.9728 and ROE was 17.54%. Still, the stock is down 66.01% year to date and 73.56% below its 52-week high of HK$216 set on 26 January, though it sits above its MA20 of HK$48.45 and just above its MA60 of HK$56.62, with a PE of 20.18x and PB of 2.58x; turnover was HK$62.0 million. However, the failure to hold HK$62.20 and the late-session pullback point to repeated selling pressure.

  4. Nov, 11

    Xipuni (2583.HK) reversed early losses to close up about 6% at HK$57.65, as southbound capital accumulation and momentum trading, rather than any company catalyst, drove the swing. The stock sank to HK$50.20 in the morning session before a one-way afternoon advance to HK$57.95, a roughly 15% intraday range on 912,000 shares and HK$49.5 million of turnover. The move extends a pattern of catalyst-free volatility: a near-40% gain over three sessions and a 17%+ single-day surge in mid-October, both without fundamental news, while a modest discounted H-share placement by the controlling shareholder triggered a 12%+ one-day pullback. The shares now sit above the MA20 of 47.80 and MA60 of 56.60, yet remain 73.36% below the 52-week high of HK$216 set on 26 January and down 65.74% year-to-date, 51.29% above the 7 October low of HK$38.04. Valuation stands at 20.37x PE and 2.61x PB on a HK$3.39 billion market cap. Though turnover of HK$49.5 million and a 1.55% turnover rate point to thin liquidity that can amplify moves.

  5. Nov, 10

    HIPINE (2583.HK) staged a spike-and-fade session as residual support from the controlling and major shareholders' voluntary non-reduction pledge met persistent selling: the stock opened at HK$51.20, ran to HK$54.75 by 13:03 BJ, up over 5% at the peak, then settled at HK$52.30, just 0.8% above the prior close of HK$51.90 on HK$36.16m turnover. Fundamentals contrast sharply with the tape, as Q2 2026 revenue of HK$192.5m rose 22.18% yoy and net profit of HK$57.2m jumped 84.79%, with a 29.73% net margin and EPS of HK$0.9728 up 51.49%, putting the shares at 18.48x PE and 2.37x PB. Yet the stock is still down 68.87% year-to-date and 75.79% below its 52-week high of HK$216 set on 26 January, holding above the MA20 of HK$47.56 but below the MA60 of HK$56.63. Though the earlier 100,000-share sale by the founder's son and the controlling shareholder continues to cap rebounds.

News